Role of azelastine nasal spray in the symptomatic treatment of seasonal allergic rhinitis

被引:0
|
作者
Bellussi, L [1 ]
Passali, D [1 ]
Finelli, F [1 ]
机构
[1] UNIV SIENA,ENT CLIN,I-53100 SIENA,ITALY
来源
关键词
D O I
暂无
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
引用
下载
收藏
页码:88 / 92
页数:5
相关论文
共 50 条
  • [41] Mometasone furoate nasal spray in seasonal allergic rhinitis
    Al Faqih, S.
    ALLERGY, 2011, 66 : 358 - 358
  • [42] INTRANASAL AZELASTINE IN SEASONAL ALLERGIC RHINITIS
    MACMAHON, MT
    NEWSONSMITH, G
    GARNHAM, SP
    BAEHRE, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (02) : 184 - 184
  • [43] Azelastine nasal spray: A review of pharmacology and clinical efficacy in allergic and nonallergic rhinitis
    Lieberman, PL
    Settipane, RA
    ALLERGY AND ASTHMA PROCEEDINGS, 2003, 24 (02) : 95 - 105
  • [44] Intranasal phototherapy versus azelastine in the treatment of seasonal allergic rhinitis
    Albu, Silviu
    Baschir, Sorin
    AURIS NASUS LARYNX, 2013, 40 (05) : 447 - 451
  • [45] Nasal Carbon Dioxide Used As Needed in the Symptomatic Treatment of Seasonal Allergic Rhinitis
    Casale, Thomas B.
    Onder, Robert F.
    Berkowitz, Robert B.
    Korenblat, Phillip E.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2018, 6 (01): : 183 - 189
  • [46] Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis
    Meltzer, EO
    Hampel, FC
    Ratner, PH
    Bernstein, DI
    Larsen, LV
    Berger, WE
    Finn, AF
    Marple, BF
    Roland, PS
    Wall, GM
    Brubaker, MJ
    Dimas, C
    Potts, SL
    Silver, LH
    Barnes, JR
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2005, 95 (06) : 600 - 606
  • [47] Triamcinolone acetonide nasal spray (Nasacort®) in the treatment of seasonal and perennial allergic rhinitis
    Bachert, C
    Darlath, W
    Janzen, B
    ALLERGOLOGIE, 1998, 21 (04) : S17 - S26
  • [48] Rhinitis: New Nasal Spray for symptomatic Treatment
    不详
    ALLERGO JOURNAL, 2022, 31 (03) : 70 - 70
  • [49] Efficacy and tolerability of azelastine nasal spray in the treatment of allergic rhinitis: Large scale experience in community practice
    Wober, W
    Crespo, CD
    Bahre, M
    CURRENT MEDICAL RESEARCH AND OPINION, 1997, 13 (10) : 617 - 626
  • [50] Olopatadine nasal spray 0.6% is superior to vehicle and non-inferior to azelastine nasal spray 0.1% when dosed twice-daily for the treatment of seasonal allergic rhinitis
    Mohar, D.
    Ratner, P.
    Shah, S.
    Drake, M.
    Crenshaw, K.
    Wall, G.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S49 - S49